GSK
867 hedge funds and large institutions have $14.5B invested in GSK in 2025 Q2 according to their latest regulatory filings, with 109 funds opening new positions, 357 increasing their positions, 248 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
867
Holders Change
+27
Holders Change %
+3.21%
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-35.71%
% of All Funds
0.12%
New
109
Increased
357
Reduced
248
Closed
59
Calls
$259M
Puts
$133M
Net Calls
+$125M
Net Calls Change
+$28.5M
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$106M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$101M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$57.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$57.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$44.4M |
